Long-term follow-up of levodopa responsiveness in generalized dystonia

Archives of Neurology

Volumn 55, Issue 10, 1998, Pages 1320-1323

  Dcwey Jr , Richard B ^a   Miicnter, Manfred D ^b   Kishore, Asha ^c   Snow, Barry J ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b MAYO CLINIC   (United States)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

LEVODOPA;

ARTICLE; CIRCADIAN RHYTHM; CLINICAL ARTICLE; DISEASE SEVERITY; DOSE TIME EFFECT RELATION; DRUG EFFECT; DRUG WITHDRAWAL; DYSTONIA; HUMAN; MOOD; MOTOR DYSFUNCTION; ONSET AGE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

ANTIPARKINSON AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DYSTONIA; FOLLOW-UP STUDIES; HUMANS; LEVODOPA; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 3543118832     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.55.10.1320     Document Type: Article

References (18)

1. Lang AE. Dopamine agonists in the treatment of dystonia. Clin Neuropharmacol. 1985:8:38-57.
2. Muenter MD, Gomez MR, Gordon H, Sharpless NS. L-dopa-responsive dystonia musculorum deformans with on-off effect [abstract]. Neurology. 1982;32: A112.
3. Nygaard TG, Takahashi H, Heiman GA, Snow BJ, Fahn S, Calne DB. Long-term treatment response and fluorodopa positron emission tomographic scanning of parkinsonism in a family with dopa-responsive dystonia. Ann Neurol. 1992:32: 603-608
4. Nygaard TG, Marsden CD, Fahn S. Dopa-responsive dystonia: long-term treatment response and prognosis. Neurology. 1991:41:174-181.
5. Burke RE, Fahn S, Marsden CD, Bressman SB, Moskowitz C, Friedman J. Validity and reliability of a rating scale for the primary torsion dystonias. Neurology. 1985:35:73-77.
6. Patlak CS, Blasberg RG. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data: generalizations. JCereb Blood Row Metab. 1985:5:584-590.
7. Vingerhoets FJ, Schulzer M, Ruth TJ, Holden JE, Snow BJ. Reproducibility and discriminating ability of fluorine-18-6-fluoro-L-dopa PET in Parkinson's disease. J Nucl Med. 1996:37:421-426.
8. Ichinose H, Ohye T, Takahashi E, et al. Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydrolase I gene. Nat Genet. 1994:8:236-242.
9. Rajput AH, Gibb QE, Zhong XH, et al. Dopa-responsive dystonia: pathological and biochemical observations in a case. Ann Neurol. 1994:35:396-402.
10. Nygaard TG. Dopa-responsive dystonia: delineation of the clinical syndrome and clues to pathogenesis. Adv Neurol. 1993:60:577-585.
11. Nygaard TG, Trugman JM, de Yebenes JG, Fahn S. Dopa-responsive dystonia: the spectrum of clinical manifestations in a large North American family. fJeurology. 1990:40:66-69.
12. Nygaard TG, Marsden CD, Duvoisin RC. Dopa-responsive dystonia. Adv Neurol. 1988:50:377-384.
13. Muenter MD, Tyce GM. L-dopa therapy of Parkinson's disease: plasma L-dopa concentration, therapeutic response, and side effects. Mayo Clin Proc. 1971 ;46: 231-239.
14. Nutt JG, Carter JH, Woodward WR. Long-duration response to levodopa. /\feurotosy. 1995:45:1613-1616.
15. Kishore A, Nygaard TG, Schulzer M, Legg B, Calne DB, Snow BJ. Striatal dopamine D2 receptors are upregulated in dopa-responsive dystonia [abstract]. Mov 0/soM996;11(suppl):105.
16. Leenders KL, Antonini A, Meinck HM, Wiendl A. Striatal dopamine D2 receptors in dopa-responsive dystonia and Parkinson's disease. In: Segawa M, Nomura Y, eds. Age-Related Dopamine-Dependent Disorders. Farmington, Conn: S Karger AG; 1995:95-100.
17. Brooks DJ. Functional imaging of movement disorders. In: Marsden CD, Fahn S, eds. Movement Disorders 3. Newton, Mass: Buttemorth-Heinemann; 1994:75-77.
18. Maricle RA, Nutt JG, Valentine RJ, Carter JH. Dose-response relationship of levodopa with mood and anxiety in fluctuating Parkinson's disease: a doubleblind, placebo-controlled study. Neurology. 1995:45:1757-1760.